Skip to main content
Top
Published in: CNS Drugs 4/2022

01-04-2022 | Muscle Relaxant | Original Research Article

Signals of Muscle Relaxant Drug Interactions Associated with Unintentional Traumatic Injury: A Population-Based Screening Study

Authors: Ghadeer K. Dawwas, Sean Hennessy, Colleen M. Brensinger, Emily K. Acton, Warren B. Bilker, Sophie Chung, Sascha Dublin, John R. Horn, Melanie M. Manis, Todd A. Miano, David W. Oslin, Thanh Phuong Pham Nguyen, Samantha E. Soprano, Douglas J. Wiebe, Charles E. Leonard

Published in: CNS Drugs | Issue 4/2022

Login to get access

Abstract

Background

Use of muscle relaxants is rapidly increasing in the USA. Little is understood about the role of drug interactions in the known association between muscle relaxants and unintentional traumatic injury, a clinically important endpoint causing substantial morbidity, disability, and death.

Objective

We examined potential associations between concomitant drugs (i.e., precipitants) taken with muscle relaxants (affected drugs, i.e., objects) and hospital presentation for unintentional traumatic injury.

Methods

In a series of self-controlled case series studies, we screened to identify drug interaction signals for muscle relaxant + precipitant pairs and unintentional traumatic injury. We used Optum’s de-identified Clinformatics® Data Mart Database, 2000–2019. We included new users of a muscle relaxant, aged 16–90 years, who were dispensed at least one precipitant drug and experienced an unintentional traumatic injury during the observation period. We classified each observation day as precipitant exposed or precipitant unexposed. The outcome was an emergency department or inpatient discharge diagnosis for unintentional traumatic injury. We used conditional Poisson regression to estimate rate ratios adjusting for time-varying confounders and then accounted for multiple estimation via semi-Bayes shrinkage.

Results

We identified 74,657 people who initiated muscle relaxants and experienced an unintentional traumatic injury, in whom we studied concomitant use of 2543 muscle relaxant + precipitant pairs. After adjusting for time-varying confounders, 16 (0.6%) pairs were statistically significantly and positively associated with injury, and therefore deemed signals of a potential drug interaction. Among signals, semi-Bayes shrunk, confounder-adjusted rate ratios ranged from 1.29 (95% confidence interval 1.04–1.62) for baclofen + sertraline to 2.28 (95% confidence interval 1.14–4.55) for methocarbamol + lamotrigine.

Conclusions

Using real-world data, we identified several new signals of potential muscle relaxant drug interactions associated with unintentional traumatic injury. Only one among 16 signals is currently reported in a major drug interaction knowledge base. Future studies should seek to confirm or refute these signals.
Appendix
Available only for authorised users
Literature
4.
go back to reference Norton R, Hyder AA, Bishai D, Peden M, et al. Unintentional injuries. In: Jamison DT, Breman JG, Measham AR, et al., editors. Disease control priorities in developing countries. 2nd ed. Washington, DC: World Bank; 2006. Norton R, Hyder AA, Bishai D, Peden M, et al. Unintentional injuries. In: Jamison DT, Breman JG, Measham AR, et al., editors. Disease control priorities in developing countries. 2nd ed. Washington, DC: World Bank; 2006.
5.
go back to reference See S. Choosing a skeletal muscle relaxant. Am Family Physician. 2008;78(3):365–70. See S. Choosing a skeletal muscle relaxant. Am Family Physician. 2008;78(3):365–70.
9.
go back to reference Logan BK, Case GA, Gordon AM. Carisoprodol, meprobamate, and driving impairment. J Forensic Sci. 2000;45(3):619–23.CrossRef Logan BK, Case GA, Gordon AM. Carisoprodol, meprobamate, and driving impairment. J Forensic Sci. 2000;45(3):619–23.CrossRef
12.
go back to reference LeRoy, Aida A, Morse, M Lee. Multiple medications and vehicle crashes: analysis of databases. Washington DC: U.S. Department of Transportation; 2008. LeRoy, Aida A, Morse, M Lee. Multiple medications and vehicle crashes: analysis of databases. Washington DC: U.S. Department of Transportation; 2008.
13.
go back to reference FDA drug safety communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. Silver Spring (MD): US Food and Drug Administration; 2016. FDA drug safety communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. Silver Spring (MD): US Food and Drug Administration; 2016.
28.
32.
go back to reference Muanda FT, Blake PG, Weir MA, et al. Association of baclofen with falls and fractures in patients with CKD. Am J Kidney Dis. 2021;78(3):470–3.CrossRef Muanda FT, Blake PG, Weir MA, et al. Association of baclofen with falls and fractures in patients with CKD. Am J Kidney Dis. 2021;78(3):470–3.CrossRef
42.
go back to reference Witenko C, Moorman-Li R, Motycka C, et al. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. P T. 2014;39(6):427–35.PubMedPubMedCentral Witenko C, Moorman-Li R, Motycka C, et al. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. P T. 2014;39(6):427–35.PubMedPubMedCentral
Metadata
Title
Signals of Muscle Relaxant Drug Interactions Associated with Unintentional Traumatic Injury: A Population-Based Screening Study
Authors
Ghadeer K. Dawwas
Sean Hennessy
Colleen M. Brensinger
Emily K. Acton
Warren B. Bilker
Sophie Chung
Sascha Dublin
John R. Horn
Melanie M. Manis
Todd A. Miano
David W. Oslin
Thanh Phuong Pham Nguyen
Samantha E. Soprano
Douglas J. Wiebe
Charles E. Leonard
Publication date
01-04-2022
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 4/2022
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.1007/s40263-022-00909-1

Other articles of this Issue 4/2022

CNS Drugs 4/2022 Go to the issue